NEFH and infection: Due to its oncolytic activity and consequently high infection rate, OAv-NFH treatment resulted in significantly greater elimination of HepG2 cells (up to ~70% at 72 h) than Adv-NFH (~20% at 72 h) when combined with VT-NF cells (Fig. 6D).